A clinical analysis of primary testicular diffuse large B-cell lymphoma in China

References

• Vitolo U, Ferreri AJM, Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol 2008;65:183–9.
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, et al.. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol 2003;21:20–7.
   PubMed Web of Science ®Google Scholar
• Lagrange JL, Ramaioli A, Theodore CH, Terrier-Lacombe MJ, Beckendorf V, Biron P, et al.. Non-Hodgkin’s lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol 2001;12:1313–9.
   PubMed Web of Science ®Google Scholar
• Seymour JF, Solomon B, Wolf MM, Janusczewicz EH, Wirth A, Prince HM. Primary large-cell non-Hodgkin’s lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma 2001;2:109–15.
   PubMedGoogle Scholar
• Zucca E. Extranodal lymphoma: a reappraisal. Ann Oncol 2008;19(Suppl 4):77–80.
   Google Scholar
• Ahmad M, Khan AH, Mansoor A, Jamal S, Mushtaq S, Khan MA, et al.. Non-Hodgkin’s lymphomas with primary manifestation in gonads — a clinicopathological study. J Pak Med Assoc 1994;44:86–8.
   PubMedGoogle Scholar
• Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases. Mod Pathol 2006;19:1521–7.
   PubMed Web of Science ®Google Scholar
• Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma 2010;51:1217–24.
   PubMed Web of Science ®Google Scholar
• Fonseca R, Habermann TM, Colgan JP, O’Neill BP, White WL, Witzig TE, et al.. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer 2000;88:154–61.
   PubMed Web of Science ®Google Scholar
• Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc 2007;99:1277–82.
   PubMed Web of Science ®Google Scholar
• Pectasides D, Economopoulos T, Kouvatseas G, Antoniou A, Zoumbos Z, Aravantinos G, et al.. Anthracycline-based chemotherapy of primary non-Hodgkin’s lymphoma of the testis: the Hellenic Cooperative Oncology Group experience. Oncology 2000;58:286–92.
   PubMed Web of Science ®Google Scholar
• Buskirk SJ, Evans RG, Banks PM, O’Connell MJ, Earle JD. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys 1982;8:1699–703.
   PubMed Web of Science ®Google Scholar
• Duncan PR, Checa F, Gowing NF, McElwain TJ, Peckham MJ. Extranodal non-Hodgkin’s lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases. Cancer 1980;45:1578–84.
   PubMed Web of Science ®Google Scholar
• Sasai K, Yamabe H, Tsutsui K, Dodo Y, Ishigaki T, Shibamoto Y, et al.. Primary testicular non-Hodgkin’s lymphoma: a clinical study and review of the literature. Am J Clin Oncol 1997;20:59–62.
   PubMed Web of Science ®Google Scholar
• Møller MB, d’Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer 1994;30A:1760–4.
   PubMed Web of Science ®Google Scholar
• Hasselblom S, Ridell B, Wedel H, Norrby K, Baum SenderM, Ekman T. Testicular lymphoma-a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol 2004;43:758–65.
   PubMed Web of Science ®Google Scholar
• Visco C, Medeiros LJ, Mesina OM, Rodriguez MA, Hagemeister FB, McLaughlin P, et al.. Non-Hodgkin’s lymphoma affecting the testis: is it curable with doxorubicin-based therapy? Clin Lymphoma 2001;2:40–6.
   PubMedGoogle Scholar
• Drillenburg P, Pals ST. Cell adhesion receptors in lymphoma dissemination. Blood 2000;95:1900–10.
   PubMed Web of Science ®Google Scholar
• Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, et al.. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 2000;96:3569–77.
   PubMed Web of Science ®Google Scholar
• Zicherman JM, Weissman D, Gribbin C, Epstein R. Best cases from the AFIP: primary diffuse large B-cell lymphoma of the epididymis and testis. Radiographics 2005;25:243–8.
   PubMed Web of Science ®Google Scholar
• Kristjansen PE, Hansen HH. Prophylactic cranial irradiation in small cell lung cancer — an update. Lung Cancer 1995;12(Suppl 3):S23–40.
   PubMedGoogle Scholar
• Verma N, Lazarchick J, Gudena V, Turner J, Chaudhary UB. Testicular lymphoma: an update for clinicians. Am J Med Sci 2008;336:336–41.
   PubMed Web of Science ®Google Scholar
• Park BB, Kim JG, Sohn SK, Kang HJ, Lee SS, Eom HS, et al.. Consideration of aggressive therapeutic strategies for primary testicular lymphoma. Am J Hematol 2007;82:840–5.
   PubMed Web of Science ®Google Scholar
• Vitolo U, Zucca E, Martelli M, Chiappella A, Baldi I, Balzarotti M, et al.. Primary diffuse large B-cell lymphoma of the testis (PTL): a prospective study of rituximab (R)-CHOP with CNS and contralateral testis prophylaxis. Results of the IELSG 10 study. Blood 2006;108:65a–6a.
   Web of Science ®Google Scholar
• Avilés A, Nambo MJ, Cleto S, Neri N, Huerta-Guzmán J. Rituximab and dose-dense chemotherapy in primary testicular lymphoma. Clin Lymphoma Myeloma 2009;9:386–9.
   PubMedGoogle Scholar
• Feugier P, Virion JM, Tilly H, Haioun C, Marit G, Macro M, et al.. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab. Ann Oncol 2004;15:129–33.
   PubMed Web of Science ®Google Scholar
• Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 2009;27:5227–32.
   PubMed Web of Science ®Google Scholar